Literature DB >> 10647958

New pathogenetic insights into the sarcoid granuloma.

C Agostini1, F Adami, G Semenzato.   

Abstract

Although the most important enigma of sarcoidosis, ie, its etiology, remains an unsolved problem, the past few years have seen remarkable advances in understanding general immunologic and molecular aspects of the mechanisms leading to granuloma formation in sarcoidosis. It is now clear that during the sarcoid inflammatory process several cytokines are secreted at sites of disease activity; in addition, high affinity receptors for cytokines participating in the granuloma development have been recently identified. This article provides a detailed description of recent data that have clarified cellular interactions governing the dynamics of granuloma formation in sarcoidosis. Together, these new results provide important insights that can refocus efforts at developing immunotherapeutic methods of inhibiting cytokine production at sites of granuloma formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647958     DOI: 10.1097/00002281-200001000-00012

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  29 in total

1.  Osseous sarcoidosis: a case series.

Authors:  Halyna Kuzyshyn; David Feinstein; Sharon L Kolasinski; Hala Eid
Journal:  Rheumatol Int       Date:  2014-11-02       Impact factor: 2.631

2.  Tattoo Koebnerization and Severe Pulmonary Hypertension.

Authors:  Matthew Patel; Karim Ladak
Journal:  Clin Med Res       Date:  2019-08-28

3.  Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study.

Authors:  Tobias Lahmer; Andreas Knopf; Ines Lanzl; Uwe Heemann; Klaus Thuermel
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

4.  M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Authors:  Stefan Prokop; Frank L Heppner; Hans H Goebel; Werner Stenzel
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 5.  Update on Treatment in Cardiac Sarcoidosis.

Authors:  Laura Young; Brett W Sperry; Rory Hachamovitch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

Review 6.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

7.  CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis.

Authors:  P Lamprecht; F Moosig; E Csernok; U Seitzer; A Schnabel; A Mueller; W L Gross
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

8.  Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis.

Authors:  H Stridh; A Planck; D Gigliotti; A Eklund; J Grunewald
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 9.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

10.  Cryptococcal pyarthrosis and sarcoidosis.

Authors:  David S Geller; John B Pope; Beverly A Thornhill; Howard D Dorfman
Journal:  Skeletal Radiol       Date:  2009-03-27       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.